Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00217919 · ClinicalTrials.gov registry record · NA
Reducing Risk Factors in Peripheral Arterial Disease
A NA study of Cardiovascular Diseases and Peripheral Vascular Diseases, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 355
- Enrollment target
- 2
- Study locations
NCT00217919: Completed NA study of Cardiovascular Diseases and Peripheral Vascular Diseases, sponsored by Northwestern University.
NCT00217919 is a NA study of Cardiovascular Diseases and Peripheral Vascular Diseases that has completed, run by Northwestern University. The registered enrollment target is 355 participants, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00217919, a NA study of Cardiovascular Diseases and Peripheral Vascular Diseases, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 355 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to compare a health-counselor mediated telephone counseling intervention to usual care to reduce low density lipoprotein cholesterol (LDL-C) levels in patients with peripheral arterial disease (PAD).
Conditions Studied
Interventions
- BEHAVIORAL Health-Counselor Mediated Telephone Counseling Intervention
Study Locations (2)
Illinois
- Northwestern University, Feinberg School of Medicine - Chicago
Massachusetts
- University of Massachusetts Medical School - Worcester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 355 participants |
| Start Date | 2006-02 |
| Est. Completion | 2009-11 |
| Phase | NA |
What the finished NCT00217919 record still lists
NCT00217919 is an interventional study that assigns participants to a tested intervention. The registered 355 participants enrollment target is mid-sized for trials with a published cap, below the 26,973-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 1 intervention - of which Health-Counselor Mediated Telephone Counseling Intervention is the first listed.
NCT00217919 reports a single indexed study location in Illinois, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00217919 about?
NCT00217919 is a clinical study titled "Reducing Risk Factors in Peripheral Arterial Disease". The purpose of this study is to compare a health-counselor mediated telephone counseling intervention to usual care to reduce low density lipoprotein cholesterol (LDL-C) levels in patients with peripheral arterial disease (PAD).
What is the current status of trial NCT00217919?
This trial is currently completed. It is a NA study. The enrollment target is 355 participants. The study started on 2006-02. Estimated completion is 2009-11.
What conditions does trial NCT00217919 study?
This clinical trial studies the following conditions: Cardiovascular Diseases, Peripheral Vascular Diseases.
What interventions are being tested in trial NCT00217919?
The interventions under investigation include: Health-Counselor Mediated Telephone Counseling Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00217919?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00217919 being conducted?
This trial has 2 study locations across Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiovascular Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00217919's enrollment target sits among peer trials
355 111th of 300 higher than 190 of 300 other Cardiovascular Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Identifying Strategies to Reduce Cardiovascular Risk Among Mothers of Young Children
RECRUITING · NA
-
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
RECRUITING · NA
-
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
RECRUITING · NA
-
Effects of Whole vs. Nonfat Milk Consumption on Body Composition in Children
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07133308 · 355 participants · Phase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- NCT07193511 · 355 participants · Phase 1
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
- NCT06077838 · 356 participants · NA
RELAXaHEAD for Headache Patients (Phase III)
- NCT06293469 · 356 participants · NA
Accelerated Flap Coverage in Severe Lower Extremity Trauma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia